302 related articles for article (PubMed ID: 29490645)
21. FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.
Liu Q; Zhao X; Frissora F; Ma Y; Santhanam R; Jarjoura D; Lehman A; Perrotti D; Chen CS; Dalton JT; Muthusamy N; Byrd JC
Blood; 2008 Jan; 111(1):275-84. PubMed ID: 17761520
[TBL] [Abstract][Full Text] [Related]
22. Antitumor action of CDK inhibitor LS-007 as a single agent and in combination with ABT-199 against human acute leukemia cells.
Xie S; Jiang H; Zhai XW; Wei F; Wang SD; Ding J; Chen Y
Acta Pharmacol Sin; 2016 Nov; 37(11):1481-1489. PubMed ID: 27569395
[TBL] [Abstract][Full Text] [Related]
23. Novel role of apatinib as a multi-target RTK inhibitor in the direct suppression of hepatocellular carcinoma cells.
Li X; Xu A; Li H; Zhang B; Cao B; Huang J
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1693-1701. PubMed ID: 29486282
[TBL] [Abstract][Full Text] [Related]
24. Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
Chen S; Xing H; Li S; Yu J; Li H; Liu S; Tian Z; Tang K; Rao Q; Wang M; Wang J
Leuk Res; 2015 Sep; 39(9):976-83. PubMed ID: 26159495
[TBL] [Abstract][Full Text] [Related]
25. CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo.
Deng M; Shi Y; Chen K; Zhao H; Wang Y; Xie S; Zhao J; Luo Y; Fang Z; Fan Y; Xu B
Exp Cell Res; 2018 Aug; 369(2):356-362. PubMed ID: 29864401
[TBL] [Abstract][Full Text] [Related]
26. Effective elimination of adult B-lineage acute lymphoblastic leukemia by disulfiram/copper complex in vitro and in vivo in patient-derived xenograft models.
Deng M; Jiang Z; Li Y; Zhou Y; Li J; Wang X; Yao Y; Wang W; Li P; Xu B
Oncotarget; 2016 Dec; 7(50):82200-82212. PubMed ID: 27203215
[TBL] [Abstract][Full Text] [Related]
27. GL-V9 exerts anti-T cell malignancies effects via promoting lysosome-dependent AKT1 degradation and activating AKT1/FOXO3A/BIM axis.
Hu P; Li H; Yu X; Liu X; Wang X; Qing Y; Wang Z; Wang H; Zhu M; Xu J; Tan R; Guo Q; Hui H
Free Radic Biol Med; 2019 Dec; 145():237-249. PubMed ID: 31560953
[TBL] [Abstract][Full Text] [Related]
28. SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemias.
Bourrié B; Brassard DL; Cosnier-Pucheu S; Zilberstein A; Yu K; Levit M; Morrison JG; Perreaut P; Jegham S; Hilairet S; Bouaboula M; Penarier G; Guiot C; Larroze-Chicot P; Laurent G; Demur C; Casellas P
Leuk Lymphoma; 2013 Jul; 54(7):1488-99. PubMed ID: 23121564
[TBL] [Abstract][Full Text] [Related]
29. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
30. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X
Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells.
Ito C; Ribeiro RC; Behm FG; Raimondi SC; Pui CH; Campana D
Blood; 1998 Feb; 91(3):1001-7. PubMed ID: 9446662
[TBL] [Abstract][Full Text] [Related]
32. [Inhibitory effect of apatinib on HCT-116 cells and its mechanism].
Yin L; Wang J; Huang FC; Zhang YF; Xu N; Wen ZQ; Li WL; Dong J
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):367-372. PubMed ID: 28377354
[TBL] [Abstract][Full Text] [Related]
33. Synergistic Lethality Effects of Apatinib and Homoharringtonine in Acute Myeloid Leukemia.
Shi Y; Xu D; Xu Y; Shen H; Zhang Y; Ye X; Jin J; Cui D; Xie W
J Oncol; 2022; 2022():9005804. PubMed ID: 36081666
[TBL] [Abstract][Full Text] [Related]
34. Apatinib inhibits glioma cell malignancy in patient-derived orthotopic xenograft mouse model by targeting thrombospondin 1/myosin heavy chain 9 axis.
Yao H; Liu J; Zhang C; Shao Y; Li X; Yu Z; Huang Y
Cell Death Dis; 2021 Oct; 12(10):927. PubMed ID: 34635636
[TBL] [Abstract][Full Text] [Related]
35. Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways.
Yang T; Yao S; Zhang X; Guo Y
Drug Des Devel Ther; 2016; 10():1389-97. PubMed ID: 27114702
[TBL] [Abstract][Full Text] [Related]
36. AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines.
Levy DS; Kahana JA; Kumar R
Blood; 2009 Feb; 113(8):1723-9. PubMed ID: 19064730
[TBL] [Abstract][Full Text] [Related]
37. The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer.
Zhao H; Li R; Wang X; Lu X; Hu M; Zhang J; Zhao X; Song X; Liu Y
J Ovarian Res; 2020 Sep; 13(1):113. PubMed ID: 32958014
[TBL] [Abstract][Full Text] [Related]
38. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
He L; Li D; Hou KZ; Liu YP
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
[TBL] [Abstract][Full Text] [Related]
39. DCZ3301, a novel aryl-guanidino inhibitor, induces cell apoptosis and cell cycle arrest via suppressing the PI3K/AKT pathway in T-cell leukemia/lymphoma.
Xiao W; Li B; Sun X; Yu D; Xie Y; Wu H; Chang S; Zhou Y; Wang H; Lan X; Xu Z; Shi J; Zhu W
Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):643-650. PubMed ID: 29688264
[TBL] [Abstract][Full Text] [Related]
40. Apatinib inhibits the proliferation of gastric cancer cells via the AKT/GSK signaling pathway
Chen Y; Chen N; Xu J; Wang X; Wei X; Tang C; Duanmu Z; Shi J
Aging (Albany NY); 2021 Aug; 13(16):20738-20747. PubMed ID: 34453028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]